These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 834188)

  • 1. Studies of the reaction of 2-formylpyridine thiosemicarbazone and its iron and copper complexes with biological systems.
    Antholine W; Knight J; Whelan H; Petering DH
    Mol Pharmacol; 1977 Jan; 13(1):89-98. PubMed ID: 834188
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.
    DeConti RC; Toftness BR; Agrawal KC; Tomchick R; Mead JA; Bertino JR; Sartorelli AC; Creasey WA
    Cancer Res; 1972 Jul; 32(7):1455-62. PubMed ID: 4555384
    [No Abstract]   [Full Text] [Related]  

  • 3. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
    Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
    Lovejoy DB; Jansson PJ; Brunk UT; Wong J; Ponka P; Richardson DR
    Cancer Res; 2011 Sep; 71(17):5871-80. PubMed ID: 21750178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial reaction of 3-ethyoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) copper(II) with Ehrlich ascites tumor cells.
    Minkel DT; Petering DH
    Cancer Res; 1978 Jan; 38(1):117-23. PubMed ID: 201367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxic and biochemical effects of ligands and metal complexes of alpha-N-heterocyclic carboxaldehyde thiosemicarbazones.
    Saryan LA; Ankel E; Krishnamurti C; Petering DH; Elford H
    J Med Chem; 1979 Oct; 22(10):1218-21. PubMed ID: 513069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.
    Yu Y; Wong J; Lovejoy DB; Kalinowski DS; Richardson DR
    Clin Cancer Res; 2006 Dec; 12(23):6876-83. PubMed ID: 17145804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor cell transplantability by iron and copper complexes of 5-substituted 2-formylpyridine thiosemicarbazones.
    Antholine WE; Knight JM; Petering DH
    J Med Chem; 1976 Feb; 19(2):339-41. PubMed ID: 1249818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity.
    Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR
    Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
    Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
    Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
    [No Abstract]   [Full Text] [Related]  

  • 11. Fate of pyruvaldehyde bis(thiosemicarbazone)-35S in male and female rodents.
    Cappuccino JG; Balis ME
    Cancer Res; 1968 Oct; 28(10):1923-31. PubMed ID: 5696926
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies on the oxidation of oxyhemoglobin by biologically active iron thiosemicarbazone complexes: relevance to iron-chelator-induced methemoglobinemia.
    Basha MT; Rodríguez C; Richardson DR; Martínez M; Bernhardt PV
    J Biol Inorg Chem; 2014 Mar; 19(3):349-57. PubMed ID: 24317633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
    Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
    Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
    Lim JK; Mathias CJ; Green MA
    J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis-histidyl hexacoordination in hemoglobins facilitates heme reduction kinetics.
    Weiland TR; Kundu S; Trent JT; Hoy JA; Hargrove MS
    J Am Chem Soc; 2004 Sep; 126(38):11930-5. PubMed ID: 15382928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation.
    Reeder BJ; Wilson MT
    Chem Res Toxicol; 2005 Jun; 18(6):1004-11. PubMed ID: 15962935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetico-mechanistic studies on methemoglobin generation by biologically active thiosemicarbazone iron(III) complexes.
    Basha MT; Bordini J; Richardson DR; Martinez M; Bernhardt PV
    J Inorg Biochem; 2016 Sep; 162():326-333. PubMed ID: 27079328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trace elements and pigments].
    Bertrand D
    Ann Nutr Aliment; 1972; 26(3):Suppl:B477-9. PubMed ID: 5085197
    [No Abstract]   [Full Text] [Related]  

  • 20. A quantitative analysis of steric and hydrophobic effects in ribonucleoside diphosphate reductase inhibition by thiosemicarbazones.
    Gupta SP; Prabhakar YS; Bindal MC; Handa A
    Arzneimittelforschung; 1984; 34(2):147-50. PubMed ID: 6372802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.